ClinicalTrials.gov
ClinicalTrials.gov Menu

Determination of Predictive Genetic Markers of Toxicity After Hypofractionated Radiotherapy in Breast Cancer Patients Post-Conservative Surgery (HYPOPRONE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01316328
Recruitment Status : Completed
First Posted : March 16, 2011
Last Update Posted : March 16, 2011
Sponsor:
Information provided by:
Regina Elena Cancer Institute